Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Comment by Reneer51on Dec 29, 2018 5:10pm

66 Views

Post# 29168459

RE:RE:RE:RE:60 Investors

Sid, some clarification. When the vast majority of people buy stock they leave it with the brokerage house in “street name”. Even though maybe 500 investors buy a given stock from a single firm it goes into the books as one shareholder. That’s what we have here. I believe there are between two and three thousand Lexaria shareholders like us and bigger than us. Certainly nowhere near 60. Hope this helps.

Bullboard Posts

Unlocking potential in TAG Oil’s Badr Oilfield Abu-Roash 'F' project